公开(公告)号：US20140350369A1

公开(公告)日：2014-11-27

申请号：US14214901

申请日：2014-03-15

申请人： ABBOTT DIABETES CARE INC.

发明人： Erwin S. Budiman ,  Gary A. Hayter ,  Kenneth J. Doniger ,  Timothy C. Dunn ,  Nathan C. Crouther ,  Glenn H. Berman ,  Howard A. Wolpert

IPC分类号： A61B5/00 ,  G06F19/00 ,  G01N33/66 ,  A61B5/145

CPC分类号： A61B5/7275 ,  A61B5/14532 ,  A61B5/4836 ,  A61B5/4848 ,  A61B5/7282 ,  A61B5/742 ,  A61B5/746 ,  G01N33/66 ,  G06F19/00 ,  G06F19/34 ,  G06F19/3456 ,  G16H15/00 ,  G16H20/10 ,  G16H50/30

摘要： A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.

摘要翻译： 系统和方法提供了基于葡萄糖数据在一段时间内的动态葡萄糖分布来确定血糖风险的葡萄糖报告，基于葡萄糖的中位数和变异性的葡萄糖控制评估和高葡萄糖变异性指标。 显示了可以看到葡萄糖水平的时间段。 中位葡萄糖目标和低葡萄糖系提供与葡萄糖变异性相结合，提供了提高或降低中值目标的效果。 低糖的可能性，中位葡萄糖与目标相比，葡萄糖低于中位数的变异性提供了基于葡萄糖数据的概率。 可以看到模式，并为治疗提供指导。

公开(公告)号：US10010291B2

公开(公告)日：2018-07-03

申请号：US14214901

申请日：2014-03-15

申请人： Abbott Diabetes Care Inc.

发明人： Erwin S. Budiman ,  Gary A. Hayter ,  Kenneth J. Doniger ,  Timothy C. Dunn ,  Nathan C. Crouther ,  Glenn H. Berman ,  Howard A. Wolpert

IPC分类号： G01N33/48 ,  A61B5/00 ,  G01N33/66 ,  A61B5/145 ,  G06F19/00 ,  G16H50/30 ,  G16H15/00

CPC分类号： A61B5/7275 ,  A61B5/14532 ,  A61B5/4836 ,  A61B5/4848 ,  A61B5/7282 ,  A61B5/742 ,  A61B5/746 ,  G01N33/66 ,  G06F19/00 ,  G06F19/34 ,  G06F19/3456 ,  G16H15/00 ,  G16H20/10 ,  G16H50/30 ,  G16Z99/00

摘要： A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.

公开(公告)号：US20160034658A1

公开(公告)日：2016-02-04

申请号：US14814279

申请日：2015-07-30

申请人： ABBOTT DIABETES CARE INC.

发明人： Glenn H. Berman ,  Hung Dinh ,  Michael R. Love ,  Mark K. Sloan

IPC分类号： G06F19/00 ,  H04L29/08

CPC分类号： G06F19/3418 ,  G16H40/40 ,  G16H40/63 ,  G16H40/67 ,  H04L63/00 ,  H04L67/12

摘要： Methods and systems for validating safety critical applications (SCAs) on uncontrolled data processing devices (UDPDs) are provided. Various combinations of checks including validation of safety critical features, validation of SCA-UDPD compatibility, and resource management are executed at various times to ensure the SCA operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.

摘要翻译： 提供了在不受控制的数据处理设备（UDPD）上验证安全关键应用程序（SCA）的方法和系统。 在不同时间执行各种检查的组合，包括安全关键特性的验证，SCA-UDPD兼容性的验证和资源管理，以确保SCA在设备上正常运行。 可以相应地控制对UDPD的SCA的操作。